CompletedPhase 2

To Compare the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars

Pakistan126 participantsStarted 2023-04-01

Plain-language summary

This study aimed to compare the efficacy of intradermal normal saline versus trichloroacetic acid (TCA) in treating atrophic acne scars. Atrophic acne scars are a common and disfiguring complication, with limited research on the use of normal saline.

Who can participate

Age range16 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 13-50 years * Clinically diagnosed patients of atrophic acne scars on face * duration of more than 6 months * no history of any procedural intervention in past 3 months Exclusion Criteria: * history of keloid, active acne, local infection, skin allergies, hypertrophic scarring, photosensitivity, or history of any comorbidities * history of use of oral isotretinoin, OCPs, steroids or immunosuppressants * pregnant or lactating females

What they're measuring

Observer Scar Assessment Scale

Timeframe: clinical assessment will be done monthly for 6 months

Trial details

NCT IDNCT06789874

SponsorSheikh Zayed Medical College

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Atrophic Acne Scar trials